• HealthTech 250
  • Our Solutions
    • HealthTech Alpha
    • Innovation Playbook
      • Digital Health Landscape Readiness Assessment
      • Competitive Benchmarking
      • Digital Health Portfolio Review
      • Next Gen Scouting
  • Our Work
  • Who We Help
    • Lifesciences
    • Insurance
    • Investors
  • Research
  • Events
  • About Us
SUBSCRIBE
  • HealthTech 250
  • Our Solutions
    • HealthTech Alpha
    • Innovation Playbook
      • Digital Health Landscape Readiness Assessment
      • Competitive Benchmarking
      • Digital Health Portfolio Review
      • Next Gen Scouting
  • Our Work
  • Who We Help
    • Lifesciences
    • Insurance
    • Investors
  • Research
  • Events
  • About Us
SUBSCRIBE

Competitive analysis in genomics for a reinsurance company

Global competitive analysis in the genomics space

Vertical :
  • Investors
  • Geography : Global

    Solution:

    • Next Gen Scouting
    • Portfolio Evaluation

    Objective

    The Corporate Venture Capital (CVC) arm of a global reinsurance company wanted to, as part of their ongoing due diligence, undertake a global competitive analysis in the genomics space before committing to their selected investment target. Based on our Similarity Score, proprietary to HealthTech Alpha, we selected 50 ventures across the globe with both full and partial product similarity. Based on the profiling of these ventures, we collaborated with our client to select a priority list of 15 ventures and conducted a full Deep Dive analysis of their products, clinical strength and unique selling proposition to build a comparison matrix to further assess their initial investment target. The examination covered Genomics ventures across the globe. Of all ventures we screened 50 and shortlisted a total of 15 companies for selection.

    Outcomes

    The data, intel and insights developed from this in-depth competitive benchmarking allowed our client to confirm their selection and pursue the investment process for their initial investment target, which was subsequently announced in Q2 2022.

    Key Results

    Number of key areas 1
    Number of ventures screened 50
    Number of ventures shortlisted 15

    Take The Next Step

    Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth

    Subscribe to our ecosystem news

    Sign up to join the only global HealthTech community.

    Subscribe

    HealthTech Alpha
    Privacy policy
    Terms

    About us
    Contact us
    Privacy policy
    Terms

    Innovation Playbook
    Healthtech alpha
    Events
    Research

    Galen Growth Asia Singapore

    Galen Growth Europe Switzerland

    Galen Growth N. America USA

    © Galen Growth 2023

    Overview

    Category

    Stage

    Total Funding

    GGA Score

    powered by
    See Full Startup Profile